CDKN1A and breast carcinoma: Here, we report that EIF1AX promotes breast cancer cell proliferation by promoting the G1/S phase transition through the transcriptional repression of p21 in a p53‐independent manner and, consequently, has a marked effect on the incidence and progression of breast cancer.